NDC 0002-7530 - Glucagon
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0002-7530
- Package NDCs from labels
- 0002-7530-01
- Manufacturer
- Eli Lilly and Company
- Effective date
- 2023-05-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Diluting Solution for Glucagon - Eli Lilly and Company | Eli Lilly and Company | 2023-05-15 | HUMAN PRESCRIPTION DRUG LABEL |
| GLUCAG0N - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2022-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Diluting Solution for Glucagon - TYA Pharmaceuticals | TYA Pharmaceuticals | 2013-10-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| glucagon | ACTIVE INGREDIENT | 76LA80IG2G | GLUCAGON KIT [ELI LILLY AND COMPANY] | 8 | |
| glucagon | ACTIVE MOIETY | 76LA80IG2G | GLUCAGON KIT [ELI LILLY AND COMPANY] | 8 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | GLUCAGON KIT [ELI LILLY AND COMPANY] | 8 | |
| lactose | INACTIVE INGREDIENT | J2B2A4N98G | GLUCAGON KIT [ELI LILLY AND COMPANY] | 8 | |
| glucagon | ACTIVE INGREDIENT | 76LA80IG2G | GLUCAGON KIT [TYA PHARMACEUTICALS] | 2 | |
| glucagon | ACTIVE MOIETY | 76LA80IG2G | GLUCAGON KIT [TYA PHARMACEUTICALS] | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | GLUCAGON KIT [TYA PHARMACEUTICALS] | 2 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | GLUCAGON KIT [TYA PHARMACEUTICALS] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.